Eyad Elkord

Also affiliated with University of Salford, Xi’an Jiaotong-Liverpool University

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

N/A

0Author DataRank · unranked

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?”.

Turning Cancer Immunotherapy to the Emerging Immune Checkpoint TIGIT: Will This Break Through the Limitations of the Legacy Approach?

Vaccines(2024)10.3390/vaccines12121306

N/A

0.292DataRank · unranked

6 citations

Eyad Elkord, Haozhe Cui

Targeting Tregs in T1DM: bridging heterogeneity, mechanisms, and clinical progress

Trends in Pharmacological Sciences(2026)10.1016/j.tips.2025.08.004

N/A

0.269DataRank · unranked

5 citations

Eyad Elkord, Yutong Li